Buğra Sağlam

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Chronic Myeloid Leukemia

Tyrosine Kinase

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Leukemia & lymphoma

Journal of clinical pharmacy and therapeutics

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Fatma Meric Yilmaz, Murat Albayrak, Pınar Tığlıoğlu, Mesut Tığlıoğlu, Buğra Sağlam, Merih Reis Aras, Senem Maral, Hacer Berna Afacan Öztürk
Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Mesut Tığlıoğlu, Pınar Cömert, Abdulkerim Yıldız, Merih Reis Aras, Buğra Sağlam, Hacer Berna Afacan Öztürk, Ayşegül Adabağ, Murat Albayrak
Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect. Journal of clinical pharmacy and therapeutics (2021)
Pınar Cömert, Murat Albayrak, Mesut Tığlıoğlu, Hacer Berna Afacan Öztürk, Merih Reis Aras, Buğra Sağlam, Senem Maral
The outcome of COVID-19 in patients with hematological malignancy. Memo 15 (1) (2021)
Mesut Tığlıoğlu, Murat Albayrak, Servihan Doğan, Fatma Yılmaz, Pınar Akyol, Buğra Sağlam, Merih Reis Aras, Abdulkerim Yıldız, Hacer Berna Afacan Öztürk, İmdat Dilek
Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis. Leukemia & lymphoma 62 (11) (2021)